Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer

Prostate cancer (PCa) is the most common malignant tumor in men. Chemotherapy with docetaxel (DTX) and novel hormonal agents such as enzalutamide (EZL) and abiraterone are the preferred first-line therapeutic regimens. Prostate-specific membrane antigen (PSMA) is overexpressed on the surface of PCa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yang, Xu, Zhenyu, Lu, Tingxun, Luo, Jia, Xue, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487954/
https://www.ncbi.nlm.nih.gov/pubmed/35980107
http://dx.doi.org/10.1080/10717544.2022.2110998

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487954/
https://www.ncbi.nlm.nih.gov/pubmed/35980107
http://dx.doi.org/10.1080/10717544.2022.2110998

Ejemplares similares